A novel role for the immunoproteasome in retinal function

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 714-723

  Hussong, Stacy A ^a,b   Roehrich, Heidi ^c   Kapphahn, Rebecca J ^a   Maldonado, Marcela ^a   Pardue, Machelle T ^d,e   Ferrington, Deborah A ^a,b  

^a Department of Ophthalmology ^*  (United States)

^b Graduate Program in the Department of Biochemistry Molecular Biology and Biophysics   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOPROTEASOME; PROTEASOME; PROTEIN DERIVATIVE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; LMP7 PROTEIN; PSMB10 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B WAVE; CATALYSIS; CONTROLLED STUDY; DARK ADAPTATION; FUNCTIONAL ASSESSMENT; KNOCKOUT MOUSE; LOCAL ADAPTATION; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; RETINA; VISION; VISUAL SYSTEM FUNCTION; WILD TYPE; AGING; ANIMAL; APOPTOSIS; C57BL MOUSE; CYTOLOGY; ELECTRORETINOGRAPHY; ENZYME ACTIVE SITE; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; IMMUNE SYSTEM; IMMUNOBLOTTING; MOUSE MUTANT; NICK END LABELING; PHYSIOLOGY; RETINA BIPOLAR GANGLION CELL;

AGING; ANIMALS; APOPTOSIS; CATALYTIC DOMAIN; CYSTEINE ENDOPEPTIDASES; ELECTRORETINOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE SILENCING; IMMUNE SYSTEM; IMMUNOBLOTTING; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEASOME ENDOPEPTIDASE COMPLEX; RETINA; RETINAL BIPOLAR CELLS; VISION, OCULAR;

EID: 79953282872     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6032     Document Type: Article

References (60)

1. Goldberg AL. Functions of the proteasome: the lysis at the end of the tunnel. Science. 1995;268:522-523.
2. Grune T, Merker K, Sandig G, Davies KJ. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun. 2003;305:709-718.
3. Dahlmann B, Ruppert T, Kuehn L, Merforth S, Kloetzel PM. Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol. 2000;303:643-653.
4. Klare N, Seeger M, Janek K, Jungblut PR, Dahlmann B. Intermediate-type 20 S proteasomes in HeLa cells: "asymmetric" subunit composition, diversity and adaptation. J Mol Biol. 2007;373:1-10.
5. Eleuteri AM, Kohanski RA, Cardozo C, Orlowski M. Bovine spleen multicatalytic proteinase complex (proteasome): replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity. J Biol Chem. 1997;272:11824-11831.
6. Díaz-Hernandez M, Hernandez F, Martín-Aparicio E, et al. Neuronal induction of immunoproteasome in Huntington's disease. J Neu-rosci. 2003;23:11653-11661.
7. Ferrington DA, Hussong SA, Roehrich H, et al. Immunoproteasome responds to injury in the retina and brain. J Neurochem. 2008;106: 158-169.
8. Mishto M, Bellavista E, Santoro A, et al. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neu-robiol Aging. 2006;27:54-66.
9. Ethen CM, Hussong SA, Reilly C, Feng X, Olsen TW, Ferrington DA. Transformation of the proteasome with age-related macular degeneration. FEBS Lett. 2007;581:885-890.
10. Hussong SA, Kapphahn RJ, Phillips SL, Maldonado M, Ferrington DA. Immunoproteasome deficiency alters retinal proteasome's response to stress. J Neurochem. 2010;113:1481-1490.
11. Kapphahn RJ, Bigelow EJ, Ferrington DA. Age-dependent inhibition of proteasome chymotrypsin-like activity in the retina. Exp Eye Res. 2007;84:646-654.
12. Louie JL, Kapphahn RJ, Ferrington DA. Proteasome function and protein oxidation in the aged retina. Exp Eye Res. 2002;75:271-284.
13. Ding Q, Reinacker K, Dimayuga E, et al. Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress. FEBS Lett. 2003;546:228-232.
14. Gavilan MP, Castano A, Torres M, et al. Age-related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects. J Neurochem. 2009;108:260-272.
15. Goldberg AL, Cascio P, Saric T, Rock KL. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol. 2002;39:147-164.
16. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994;78:761-771.
17. Nguyen TP, Soukup VM, Gelman BB. Persistent hijacking of brain proteasomes in HIV-associated dementia. Am J Pathol. 2010;176: 893-902.
18. Basler M, Moebius J, Elenich L, Groettrup M, Monaco JJ. An altered T cell repertoire in MECL-1-deficient mice. J Immunol. 2006;176: 6665-6672.
19. Caudill CM, Jayarapu K, Elenich L, Monaco JJ, Colbert RA, Griffin TA. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J Immunol. 2006;176:4075-4082.
20. Fehling HJ, Swat W, Laplace C, et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science. 1994;265: 1234-1237.
21. Kapphahn RJ, Giwa BM, Berg KM, et al. Retinal proteins modified by 4-hydroxynonenal: identification of molecular targets. Exp Eye Res. 2006;83:165-175.
22. Morrow EM, Chen CM, Cepko CL. Temporal order of bipolar cell genesis in the neural retina. Neural Dev. 2008;3:2.
23. Phillips MJ, Walker TA, Choi HY, et al. Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30. Invest Ophthalmol Vis Sci. 2008; 49:2148-2155.
24. Guillet R, Wyatt J, Baggs RB, Kellogg CK. Anesthetic-induced corneal lesions in developmentally sensitive rats. Invest Ophthal-mol Vis Sci. 1988;29:949-954.
25. Robson JG, Saszik SM, Ahmed J, Frishman LJ. Rod and cone contributions to the a-wave of the electroretinogram of the macaque. J Physiol. 2003;547:509-530.
26. Akula JD, Hansen RM, Martinez-Perez ME, Fulton AB. Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:4351-4359
27. Akula JD, Mocko JA, Moskowitz A, Hansen RM, Fulton AB. The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48: 5788-5797.
28. Gresh J, Goletz P, Crouch RK, Rohrer B. Structure-function analysis of rods and cones in juvenile, adult, and aged C57BL/6 and Balb/c mice. Vis Neurosci. 2003;20:211-220.
29. /~ mice during development and aging. Invest Ophthalmol Vis Sci. 2003;44:310-315
30. Jeon CJ, Strettoi E, Masland RH. The major cell populations of the mouse retina.JNeurosci. 1998;18:8936-8946.
31. Colledge M, Snyder EM, Crozier RA, et al. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron. 2003;40:595-607.
32. Wheeler TC, Chin L, Li Y, Roudabush FL, Li L. Regulation of synaptophysin degradation by mammalian homologues of Seven in Absentia. J Biol Chem. 2002;277:10273-10282.
33. Brandstatter JH, Dick O, Boeckers TM. The postsynaptic scaffold proteins ProSAP1/Shank2 and Homer1 are associated with gluta-mate receptor complexes at rat retinal synapses. J Comp Neurol. 2004;475:551-563.
34. Sharma RK, O'Leary TE, Fields CM, Johnson DA. Development of the outer retina in the mouse. Brain Res Dev Brain Res. 2003; 145:93-105.
35. Morgans CW, Zhang J, Jeffrey BG, et al. TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci USA. 2009;106:19174-19178.
36. Koike C, Obara T, Uriu Y, et al. TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci USA. 2010;107:332-337.
37. Jaissle GB, May CA, Reinhard J, et al. Evaluation of the rhodopsin knockout mouse as a model of pure cone function. Invest Ophthalmol Vis Sci. 2001;42:506-513
38. Maeda T, Lem J, Palczewski K, Haeseleer F. A critical role of CaBP4 in the cone synapse. Invest Ophthalmol Vis Sci. 2005;46:4320-4327.
39. Seeliger MW, Grimm C, Ståhlberg F, et al. New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet. 2001;29:70-74.
40. Haeseleer F, Imanishi Y, Maeda T, et al. Essential role of Ca2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat Neurosci. 2007;7:1079-1087.
41. Mansergh F, Orton NC, Vessey JP, et al. Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synaptic transmission and cellular organization in mouse retina. Hum Mol Genet. 2005;14:3035-3046.
42. Masu M, Iwakabe H, Tagawa Y, et al. Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell. 1995;80:757-765.
43. Wycisk KA, Budde B, Feil S, et al. Structural and functional abnormalities of retinal ribbon synapses due to Cacna2d4 mutation. Invest Ophthalmol Vis Sci. 2006;47:3523-3530.
44. Dick O, tom Dieck S, Altrock WD, et al. The presynaptic active zone protein bassoon is essential for photoreceptor ribbon synapse formation in the retina. Neuron. 2003;37:775-786.
45. Satz JS, Philp AR, Nguyen H, et al. Visual impairment in the absence of dystroglycan.JNeurosci. 2009;29:13136-13146.
46. _/y) mouse retina and modification by rAAV-Rs1 gene delivery. Invest Ophthalmol Vis Sci. 2008;49:3677-3686.
47. Behndig A, Svensson B, Marklund SL, Karlsson K. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci. 1998;39:471-475.
48. Hashizume K, Hirasawa M, Imamura Y, et al. Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol. 2008;172:1325-1331.
49. Justilien V, Pang J, Renganathan K, et al. SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci. 2007;48:4407-4420.
50. Galbinur T, Obolensky A, Berenshtein E, et al. Effect of para-aminobenzoic acid on the course of retinal degeneration in the rd10 mouse. J Ocul Pharmacol Ther. 2009;25:475-482.
51. Lu L, Oveson BC, Jo YJ, et al. Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage. An-tioxid Redox Signal. 2009;11:715-724.
52. Sasaki M, Ozawa Y, Kurihara T, et al. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthal-mol Vis Sci. 2009;50:1433-1439.
53. Teoh CY, Davies KJ. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis. Arch Biochem Biophys. 2004;423:88-96.
54. Cai ZP, Shen Z, Van Kaer L, Becker LC. Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J. 2008;22:4248-4257.
55. Hayashi T, Faustman DL. NOD mice are defective in proteasome production and activation of NF-kB. Mol Cell Biol. 1999;19:8646-8659.
56. Hayashi T, Faustman DL. Selected contribution: association of gender-related LMP2 inactivation with autoimmune pathogenesis. JApplPhysiol. 2001;91:2804-2815
57. Kisselev AF, Akopian TN, Woo KM, Goldberg AL. The size of peptides generated from protein by mammalian 26 and 20 S proteasomes: implications for understanding the degradative mechanism and antigen presentation. J Biol Chem. 1999;274: 3363-3371.
58. Fricker LD, Snyder SH. Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypepti-dase. JBiol Chem. 1983;258:10950-10955
59. Zhou P, Zanelli E, Smart M, David C. Genomic organization and tissue expression of mouse proteasome gene Lmp-2. Genomics. 1993;16:664-668.
60. Stohwasser R, Kuckelkorn U, Kraft R, Kostka S, Kloetzel PM. 20S proteasome from LMP7 knock out mice reveals altered proteolytic activities and cleavage site preferences. FEBSLett. 1996;383:109-113